23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid
Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...
23andMe considers selling its telehealth unit Lemonaid
Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...
telecareaware.com6h
Straws in the wind? 23andMe considering Lemonaid telehealth sale, announces Discover23 research offering with Lifebit
Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...
23andMe exploring possible sale of telehealth business, BI reports
Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...
AOL4d
23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid
The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.